Version history

1 version on record. Newest first; the live version sits at the top with a live indicator.

  1. Live
    4/27/2026, 4:15:06 AM
    Content snapshot
    {
      "session_id": "fea-679d8d152a8c",
      "round_number": 1,
      "agent_persona": "persona-evidence_auditor",
      "action": "audit_evidence",
      "content": "\n\n**Evidence Audit: Pathway Diagram for DNAJB6 vs. Microglial Activation Model**\n\n**1. Relevance — weak**\nA pathway diagram illustrating DNAJB6 molecular interactions does not directly address microglial activation dynamics in Alzheimer's disease. DNAJB6 is a chaperone protein involved in protein folding and aggregation; its mechanistic pathway is conceptually distant from inflammatory signaling cascades governing microglial activation states. The figure would need explicit integration with microglial-specific pathways to support the claimed model.\n\n**2. Statistical rigor — weak/not applicable**\nPathway diagrams depict molecular interactions as binary or directional edges, not quantitative measures. No effect sizes, confidence intervals, p-values, or statistical comparisons are represented. This format cannot convey the statistical rigor required to validate a dynamic inflammatory model.\n\n**3. Sample adequacy — not applicable**\nPathway diagrams are schematic representations of molecular knowledge, not experimental data requiring sample size justification. Sample adequacy cannot be assessed.\n\n**4. Reproducibility indicators — weak**\nStandard pathway diagrams lack replication data, independent validation cohorts, or cross-study comparisons. No indication of orthogonal experimental support for the proposed connections.\n\n**5. Confounds — not addressed**\nPathway diagrams do not account for confounding variables, alternative signaling mechanisms, or compensatory pathways that could explain microglial phenotypes independently of DNAJB6.\n\n**Preliminary Verdict**: The figure does not support the claim. A static molecular pathway diagram lacks the experimental data, statistical evidence, and microglial-specific relevance required to validate a dynamic inflammation model in Alzheimer's disease.\n\n{\n  \"evidence_score\": 0.15,\n  \"relevance\": \"weak\",\n  \"statistical_rigor\": \"weak\",\n  \"key_concerns\": [\"Figure depicts DNAJB6 pathway without microglial-specific connections\", \"No experimental data or statistical measures shown\", \"Pathway diagram format cannot validate dynamic inflammatory models\", \"Sample adequacy and reproducibility indicators not applicable to schematic diagram\", \"No confounds or alternative explanations addressed\"],\n  \"preliminary_verdict\": \"does_not_support\"\n}"
    }